Wispr seeks funding that would value AI voice startup at $2B

The company behind the Wispr Flow dictation tool is reportedly raising $260M in a Series B round, signaling continued investor appetite for AI productivity tools.

Share

Add us on Google by Editorial Team May. 14, 2026

Wispr, the AI startup behind the voice dictation tool Wispr Flow, is reportedly in discussions to raise $260 million at a valuation of $2 billion. The funding round, described as a Series B, hasn’t been publicly confirmed by the company, but the reported terms would place Wispr squarely in the upper tier of AI startups that have captured investor imagination over the past two years.

Advertisement " document.getElementById("alkimi-leaderboard").innerHTML = iFrame var iframeDoc = document.getElementById(idIFrame).contentWindow.document pbjs.renderAd(iframeDoc, highestCpmBids[0].adId); } } setTimeout(function () { renderAds(); }, FAILSAFE_TIMEOUT);

Wispr Flow is a voice dictation application designed to let users control their computers and compose text using natural speech. The product sits at the intersection of two powerful trends: large language models have made natural language processing dramatically more accurate and context-aware, and the broader AI productivity wave has convinced both consumers and enterprise buyers that the old keyboard-and-mouse paradigm is ripe for disruption.

The discussions are reportedly still in early stages, which means the final terms could shift. The competitive landscape is worth noting. Apple, Google, Microsoft, and OpenAI all have voice capabilities baked into their ecosystems. Building a standalone voice product means competing with companies that can bundle similar functionality into existing platforms at zero marginal cost.

Wispr’s fundraise has no direct crypto angle. There are no tokens, no blockchain integrations, and no decentralized protocols involved in the reported deal. The risk for Wispr is execution. Until the round officially closes, the numbers remain aspirational rather than confirmed.

Disclosure: This article was edited by Editorial Team. For more information on how we create and review content, see our Editorial Policy.